111 Inc to Attend the JP Morgan 2020 Healthcare Conference in San Francisco, January 14-15, 2020

SHANGHAI, Jan. 3, 2020 /PRNewswire/ — 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced that the Company will attend  the JP Morgan 2020 Healthcare Conference in San Francisco, CA, USA, January 14-15, 2020 and meet with institutional investors.

Mr. Junling Liu, Co-founder, Chairman and CEO is scheduled to present a keynote speech titled Capturing Opportunities in China’s Pharmaceutical and Healthcare Industry in an Era of Transformation on January 15th. Mr. Liu and Mr. Luke Chen, CFO, will also be available to meet with investors attending the conference.

For additional information, please contact your JP Morgan representative.

About 111, Inc.

111, Inc. (NASDAQ: YI) (“111” or the “Company”) is a leading integrated online and offline healthcare platform in China. The Company provides hundreds of millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy and indirectly through its offline pharmacy network. 111 also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation and electronic prescription services. In addition to providing direct services to consumers through its online retail pharmacy, 111 also enables offline pharmacies to better serve their customers. The Company’s online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. The Company’s new retail platform, by integrating the front and back ends of the pharmaceutical supply chain, has formed a smart supply chain, which transforms the flow of pharmaceutical products to pharmacies and modernizes how they serve their customers.

For more information on 111, please visit http://ir.111.com.cn.

For more information, please contact:

111, Inc.
IR Director
Ms. Monica Mu
E-mail: ir@111.com.cn  

Christensen

In China
Mr. Christian Arnell
Phone: +86-10-5900-1548
E-mail: carnell@christensenir.com

In US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
Email: lbergkamp@christensenir.com

View original content:http://www.prnewswire.com/news-releases/111-inc-to-attend-the-jp-morgan-2020-healthcare-conference-in-san-francisco-january-14-15-2020-300980928.html

SOURCE 111, Inc.

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

13 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

1 hour ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

1 hour ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

1 hour ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

1 hour ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

1 hour ago